Grade: Pharmaceutical Grade

Factory Location: Taizhou,Zhejiang,China

Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa

Sample Provided: yes

Payment Terms: L/L

Apremilast was approved by the United States Food and Drug Administration in 2014 for treatment of adults with active psoriatic arthritis and moderate to severe plaque psoriasis.